Hem › Lupusnefrit › New York
Kliniska studier för Lupusnefrit i New York
16 studier för Lupusnefrit söker deltagare vid platser i New York.
Städer i New York
Officiell studietext (engelska)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 1 okt. 2026 · NCT05268289Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
- Circuit Clinical, Orchard Park
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06711887A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
RekryterarFas 2
Ålder 16 till 70 · Alla kön · Uppdaterad 17 sep. 2026 · NCT07328581VIBRANT: VIB4920 for Active Lupus Nephritis
- Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset
- Hospital for Special Surgery, New York: Division of Rheumatology, New York
- Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT05201469The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Hospital for Special Surgery, New York
- Children's Hospital at Montefiore, New York
RekryterarFas 2
Ålder 8 till 20 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05538208A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 10 sep. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Cohen Children's Medical Center of New York, Queens
RekryterarFas 2
Ålder 5 till 17 · Alla kön · Uppdaterad 3 sep. 2026 · NCT05039619RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
RekryterarFas 1/2
Ålder 18 till 65 · Alla kön · Uppdaterad 26 aug. 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
RekryterarFas 2
Ålder 12 till 65 · Alla kön · Uppdaterad 24 aug. 2026 · NCT07053800PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Buffalo Rheumatology and Medicine, PLLC, Orchard Park
RekryterarFas 4
Ålder 18 till 75 · Alla kön · Uppdaterad 3 aug. 2026 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, New York
- Nkarta Investigational Site, Stony Brook
- Nkarta Investigational Site, Syracuse
RekryterarFas 1/2
Ålder 18 till 75 · Alla kön · Uppdaterad 4 juni 2026 · NCT06557265A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
RekryterarFas 1
Ålder 12 till 70 · Alla kön · Uppdaterad 22 maj 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- och 1 fler
RekryterarObservationsstudie
Ålder 18 till 110 · Alla kön · Uppdaterad 15 apr. 2026 · NCT05934149Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
RekryterarTidig fas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 nov. 2025 · NCT07107659Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
- The Rogosin Institute, New York
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 4 apr. 2025 · NCT01802034Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.